| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/07/2023 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (Right to Buy) | 14k | $23.09 | $323.3k | | 06/07/2023 |
| 05/23/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.2k | $0.00 | $0 | | 05/23/2023 |
| 05/18/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 3.5k | $189.87 | $655.8k | | 05/18/2023 |
| 02/23/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Restricted Stock Units | 136 | $0.00 | $0 | | 02/23/2023 |
| 06/16/2022 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 15k | $6.80 | $102k | | 06/16/2022 |
| 05/24/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 5k | $0.00 | $0 | | 05/24/2022 |
| 05/18/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 5.2k | $128.31 | $661.2k | | 05/18/2022 |
| 02/23/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Restricted Stock Units | 136 | $0.00 | $0 | | 02/23/2022 |
| 07/15/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4k | $171.95 | $693.3k | | 07/15/2021 |
| 06/29/2021 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 13.3k | $28.20 | $374.7k | | 06/29/2021 |
| 06/29/2021 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 13.3k | $28.20 | $374.7k | | 06/29/2021 |
| 05/25/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 5.1k | $0.00 | $0 | | 05/25/2021 |
| 01/12/2021 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 26.6k | $27.71 | $736.3k | | 01/12/2021 |
| 08/31/2020 | BIOMARIN PHARMACEUTICAL INC | BMRN | Purchase | Common Stock | 11.9k | $78.22 | $930.8k | | 08/31/2020 |
| 08/31/2020 | BIOMARIN PHARMACEUTICAL INC | BMRN | Purchase | Common Stock | 900 | $78.84 | $71k | | 08/31/2020 |
| 07/01/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4.6k | $148.77 | $681.5k | | 07/01/2020 |
| 05/27/2020 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.3k | $0.00 | $0 | | 05/27/2020 |
| 04/23/2020 | Avery Dennison Corp | AVY | Exercise | Common Stock | 1.4k | $107.56 | $152.1k | | 04/23/2020 |
| 04/23/2020 | Avery Dennison Corp | AVY | Exercise | 2019 Director RSU Award | 1.4k | $0.00 | $0 | | 04/23/2020 |
| 02/03/2020 | Avery Dennison Corp | AVY | Sale | Common Stock | 5k | $132.72 | $667.2k | | 02/03/2020 |
| 02/03/2020 | Avery Dennison Corp | AVY | Exercise | 2010 Director Stock Option | 5k | $38.18 | $191.9k | | 02/03/2020 |
| 07/01/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 9k | $72.01 | $648.1k | | 07/01/2019 |
| 06/04/2019 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.4k | $0.00 | $0 | | 06/04/2019 |
| 05/01/2019 | Avery Dennison Corp | AVY | Exercise | Common Stock | 641 | $109.63 | $70.3k | | 05/01/2019 |
| 05/01/2019 | Avery Dennison Corp | AVY | Exercise | Common Stock | 1.3k | $109.63 | $146.5k | | 05/01/2019 |
| 05/01/2019 | Avery Dennison Corp | AVY | Grant | 2019 Director RSU Award | 1.4k | $0.00 | $0 | | 05/01/2019 |
| 05/01/2019 | Avery Dennison Corp | AVY | Exercise | 2016 Director RSU Award | 641 | $0.00 | $0 | | 05/01/2019 |
| 05/01/2019 | Avery Dennison Corp | AVY | Exercise | 2018 Director RSU Award | 1.3k | $0.00 | $0 | | 05/01/2019 |
| 11/27/2018 | Avery Dennison Corp | AVY | Sale | Common Stock | 2k | $93.00 | $186k | | 11/27/2018 |
| 11/27/2018 | Avery Dennison Corp | AVY | Exercise | 2009 Director Stock Option | 2k | $20.64 | $41.3k | | 11/27/2018 |
| 06/20/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 9k | $105.26 | $947.3k | | 06/20/2018 |
| 06/05/2018 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.3k | $0.00 | $0 | | 06/05/2018 |
| 05/01/2018 | Avery Dennison Corp | AVY | Grant | 2018 Director RSU Award | 1.3k | $0.00 | $0 | | 05/01/2018 |
| 05/01/2018 | Avery Dennison Corp | AVY | Exercise | Common Stock | 747 | $104.80 | $78.3k | | 05/01/2018 |
| 05/01/2018 | Avery Dennison Corp | AVY | Exercise | Common Stock | 641 | $104.80 | $67.2k | | 05/01/2018 |
|